Alopecia areata is a disorder related to loss of hair. It is an autoimmune disorder, wherein the immune system attacks the hair follicles and induces hair fall. Alopecia areata causes certain signs and symptoms such as bald patches, sudden loss of hair, excessive hair-fall, and itching on scalp. It leads to different types of alopecia diseases such as alopecia totalis, alopecia semiuniversalis, and alopecia universalis, where an individual suffers from facial to body hair loss. The risk factors associated with alopecia areata are genetic inheritance, stress, viral infections, or vitamin D deficiency. Research institutes and laboratories are focusing on delivery of alopecia areata treatment through different therapeutic and diagnostic procedures. Modulation of unique technology and approach toward diagnosis of alopecia areata ensures better functional ability to cure the common types of hair fall diseases. However, new developments in pharmological and hair treatment approaches allow imaging of the disorder at the cellular and molecular level. This is paving the way for early diagnosis and treatment of early hair fall disorder.
High incidence of hair fall disorders among the younger generation, rise in health effects due to environmental changes, increase in research and development initiatives, and advent of high-throughput screening (HTS) for drug discovery for alopecia areata are the key factors driving the global alopecia areata treatment market. According to the Dermatology News, 2018, alopecia areata affects approximately 75 million people across the world, including 7 million with alopecia totalis or universalis. In Sinclair Dermatology Center, East Melbourne, nearly 30,000 patients per year get treatment for alopecia areata disorder. Increase in the number of patients with alopecia disorder and rise in awareness about therapeutics & drugs for alopecia areata treatment are projected to fuel the global alopecia areata treatment market. However, side effects of drugs and lengthy procedures are expected to hamper the growth of the alopecia areata treatment market.
The global alopecia areata treatment market can be segmented based on therapy type, distribution channel, and region. In terms of therapy type, the alopecia areata treatment market can be classified into steroids, vasodilator, anti-Inflammatory drugs, immunosuppressive drugs, UV light therapy, and others. Corticosteroid drugs is a rapidly expanding segment due to anti-inflammatory and lipid-regulating properties which is also increasingly used in clinical trials across the globe. In terms of distribution channel, the global alopecia areata treatment market can be categorized into online pharmacies, hospital pharmacies, retail pharmacies, and others.
In terms of region, the global alopecia areata treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the global alopecia areata treatment market in 2017 due to increase in funding for development of research and health care infrastructure. Increase in incidence of hair fall diseases such as alopecia areata and early phase diagnosis & treatment drive the biotechnology & pharmaceutical market, which in turn is expected to boost the alopecia areata treatment market in North America. Europe was the second largest market for alopecia areata treatment in 2017 owing to favorable government policies for expansion of health care infrastructure and hair treatment companies. The alopecia areata treatment market in Asia Pacific is likely to expand at a high CAGR during the forecast period due to increase in young population with alopecia areata disorder, changing lifestyle, rise in awareness among patients, and surge in per capita expenditure. Additionally, economic growth in India and China supports health care infrastructure and expansion of pharmaceutical companies and biotech labs.
Major players operating in the global alopecia areata treatment market include Pfizer, Inc., TetraLogic Pharmaceuticals Corporation, Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Cadila Pharmaceuticals, Perrigo Company plc, Teva Pharmaceutical Industries Ltd., and Schering-Plough Corporation.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.